Pohang-si, South Korea

Jeong A Yang


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator in Drug Delivery: Jeong A Yang

Introduction: Jeong A Yang is an accomplished inventor based in Pohang-si, South Korea. With a focus on bioconjugation and drug delivery systems, he has made remarkable contributions to the field of medical innovations. His work has significant implications for the treatment of liver diseases and enhancing the efficacy of protein drugs.

Latest Patents: Jeong A Yang holds a patent for "Hyaluronic Acid-Protein Conjugates and Method for Preparing Same." This innovation involves a hyaluronic acid (HA)-aldehyde derivative conjugated to the N-terminus of a protein. The conjugate demonstrates enhanced bioconjugation efficiency and prolonged medicinal effects. Specifically designed for treating liver diseases, this HA-protein conjugate allows for controlled liver-targeting properties by altering the aldehyde substitution rate, making it a valuable asset in developing effective protein drug delivery systems.

Career Highlights: Jeong A Yang's career is marked by his role at the Postech Academy-Industry Foundation, where he engages in cutting-edge research and development. His expertise in protein conjugation and drug delivery continues to pave the way for novel therapeutic approaches in the medical field.

Collaborations: Throughout his career, Jeong A Yang has collaborated with notable peers, including Sei Kwang Hahn and Seung Kyu Yoon. These partnerships have fostered a collaborative environment that drives innovation and enhances research outcomes in their shared pursuit of advancing medical technologies.

Conclusion: Jeong A Yang's contributions to the field of bioconjugation and drug delivery exemplify the transformative potential of innovative inventions. His patent on hyaluronic acid-protein conjugates not only showcases his inventiveness but also underscores the importance of targeted treatment options for liver diseases. With ongoing partnerships and a commitment to research, Jeong A Yang continues to impact the landscape of medical innovations significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…